Trials / Terminated
TerminatedNCT05423327
Genetic Data Collection in Adult Participants to Identify Genetic Variants of Known Importance in Non-alcoholic Steatohepatitis (NASH)
Cross-Sectional Study to Determine Distribution of Genetic Variants Among Subjects at Risk of, or With Known Non-alcoholic Steatohepatitis (NASH)
- Status
- Terminated
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 5,311 (actual)
- Sponsor
- Regeneron Pharmaceuticals · Industry
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
Collection of clinical and genetic data to help identify individuals that carry genetic variants of known importance in Non-alcoholic Steatohepatitis (NASH)
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | No Intervention | Single blood draw |
Timeline
- Start date
- 2021-12-09
- Primary completion
- 2022-10-27
- Completion
- 2022-10-27
- First posted
- 2022-06-21
- Last updated
- 2023-03-17
Locations
50 sites across 5 countries: United States, Brazil, Mexico, Puerto Rico, South Korea
Source: ClinicalTrials.gov record NCT05423327. Inclusion in this directory is not an endorsement.